Emerg Infect Dis by Junglen, Sandra et al.
 Page 1 of 8 
Article DOI: http://dx.doi.org/10.3201/eid2112.141840 
No Evidence of Gouléako and Herbert 
Virus Infections in Pigs, Côte d’Ivoire and 
Ghana 
Technical Appendix 
Additional Methods and Results 
Growth Kinetics 
Porcine kidney (PK)-15 cells, human embryonic kidney (HEK)-293 cells, and human 
hepatocellular carcinoma (HuH)-7 cells were infected with Gouléako virus (GOLV), Herbert 
virus (HEBV), and vesicular stomatitis virus (VSV) as a positive control at multiplicities of 
infection (MOI) of 1, as described (1,2). Cell culture supernatants were analyzed for viral 
genome copy numbers at 0, 3, and 6 days postinfection by real-time reverse transcription 
PCR (1,2). 
Amplification of GOLV Glycoprotein Precursor Gene Sequences 
RNA was extracted from infected C6/36 cells by using the Viral RNA Kit (QIAGEN, 
Hilden, Germany) and cDNA synthesis was performed by using SuperScript III (Thermo 
Fisher Scientific, Lithuania) Glycoprotein precursor gene fragments were amplified by using 
primers based on strain GOLV/A5/CI/2005 and Platinum Taq polymerase, according to the 
manufacturer’s instructions (Thermo Fisher Scientific, Lithuania). PCR products were 
analyzed by agarose gel electrophoresis and sequenced by Seqlab (Göttingen, Germany). 
Sequences were deposited in the GenBank database (National Center for Biotechnology 
Information, Bethesda, MD, USA) under accession number KT387771–KT387796. 
Phylogenetic Analyses 
GOLV glycoprotein precursor gene and HEBV RdRp sequences were aligned by 
using the multiple sequence alignment program MAFFT 
(http://wiki.hpc.ufl.edu/doc/PhyML); maximum likelihood analyses were inferred by using 
PhyML (https://code.google.com/p/phyml/) with the HKY85 substitution matrix and 1,000 
bootstrap replicates in Geneiuos (Biomatters, Aukland, New Zealand; 
http://www.geneious.com/). 
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PCR Screening of Swine Serum Samples 
Ethical review and clearances of animal handling procedure were obtained from the 
Ghana Forestry Commission of the Ministry of Food and Agriculture. RNA was extracted 
from 15µL of porcine serum samples mixed with 55µL Dulbecco’s Phosphate-Buffered 
Saline by using the QIAamp Viral RNA Mini Kit (QIAGEN, Hilden, Germany). Random 
cDNA synthesis was performed by using SuperScript III (Thermo Fisher Scientific, 
Lithuania). Viral genome copies were measured by real-time reverse–transcription PCR, as 
described previously (1,2). The Technical Appendix Table shows samples tested and results. 
Recombinant Nucleocapsid Immunofluorescence Assay (IFA) 
Porcine serum samples were screened for presence of antibodies against the GOLV 
and HEBV viruses in 1:20 dilutions by rIFA as described (3). C-terminally FLAG-tagged full 









TTGTTGATCAGTG). The amplified genes were then cloned into a pCG1 eukaryotic 
expression vector. 
Plasmids were sequence confirmed. Transfected cells were used in indirect 
immunofluorescence assays with goat anti-swine IgG-Alexa Fluor 488 conjugate (Sigma, St. 
Louis, USA) in 1:200 dilution for detection of bound swine serum antibody. A rabbit anti-
FLAG antibody and goat anti-rabbit fluorescein-labeled conjugate in 1:200 dilution 
(Dianova, Hamburg, Germany) were used to confirm expression of viral proteins. A c-
terminal flag tag will be expressed only when the upstream viral protein ORF is intact. Cell 
nuclei were stained with ProLong Gold Antifade Mountant (Thermo Fisher Scientific, 
Lithuania) with DAPI (4’, 6-diamidino-2-phynylindole). 
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Technical Appendix Table. Porcine serum samples tested for infection with GOLV and HEBV by using real-time reverse 
transcription PCR and rIFA, in Côte d’Ivoire and Ghana, 2008–2011* 
Sample ID Sex 
Age, 
mo† Origin 
 rIFA Viral RNA 
Year GOLV HEBV GOLV HEBV 
CI-S 01 Male 12 Gouléako, CI 2008 Neg Neg Neg Neg 
CI-S 02 Female 12 Gouléako, CI 2008 Neg Neg Neg Neg 
CI-S 03 Female 12 Gouléako, CI 2008 Neg Neg Neg Neg 
CI-S 04 Male 11 Gouléako, CI 2008 Neg Neg Neg Neg 
CI-S 05 Female 9 Gouléako, CI 2008 Neg Neg Neg Neg 
CI-S 06 Female 3 Gouléako, CI 2008 Neg Neg Neg Neg 
CI-S 07 Female 3 Gouléako, CI 2008 Neg Neg Neg Neg 
CI-S 08 Male 3 Gouléako, CI 2008 Neg Neg Neg Neg 
CI-S 09 Female 3 Gouléako, CI 2008 Neg Neg Neg Neg 
CI-S 10 Female 6 Gouléako, CI 2008 Neg Neg Neg Neg 
CI-S 11 Female 3 Gouléako, CI 2008 Neg Neg Neg Neg 
CI-S 12 Female 3 Gouléako, CI 2008 Neg Neg Neg Neg 
CI-S 13 Female 12 Gouléako, CI 2008 Neg Neg Neg Neg 
CI-S 14 Male 3 Gouléako, CI 2008 Neg Neg Neg Neg 
CI-S 15 Female 8 Gouléako, CI 2008 Neg Neg Neg Neg 
CI-S 16 Female 4 Gouléako, CI 2008 Neg Neg Neg Neg 
CI-S 17 Female 4 Gouléako, CI 2008 Neg Neg Neg Neg 
CI-S 18 Female 2 Gouléako, CI 2008 Neg Neg Neg Neg 
CI-S 19 Male 2 Gouléako, CI 2008 Neg Neg Neg Neg 
CI-S 20 Female 4 Gouléako, CI 2008 Neg Neg Neg Neg 
CI-S 21 Male 4 Gouléako, CI 2008 Neg Neg Neg Neg 
CI-S 22 Female 2 Gouléako, CI 2008 Neg Neg Neg Neg 
CI-S 23 Female 3 Gouléako, CI 2008 Neg Neg Neg Neg 
CI-S 24 Female 2 Gouléako, CI 2008 Neg Neg Neg Neg 
CI-S 25 Female 3 Gouléako, CI 2008 Neg Neg Neg Neg 
CI-S 26 Female 3 Gouléako, CI 2008 Neg Neg Neg Neg 
CI-S 27 Female 3 Gouléako, CI 2008 Neg Neg Neg Neg 
CI-S 28 Female 5 Gouléako, CI 2008 Neg Neg Neg Neg 
GH-S 01 Female 24 Amanfrom, GH 2011 Neg Neg Neg Neg 
GH-S 02 Female 6 Amanfrom, GH 2011 Neg Neg Neg Neg 
GH-S 04 Male 6 Amanfrom, GH 2011 Neg Neg Neg Neg 
GH-S 05 Female 36 Amanfrom, GH 2011 Neg Neg Neg Neg 
GH-S 06 Male 6 Amanfrom, GH 2011 Neg Neg Neg Neg 
GH-S 07 Male 6 Amanfrom, GH 2011 Neg Neg Neg Neg 
GH-S 08 Female 8 Amanfrom, GH 2011 Neg Neg Neg Neg 
GH-S 09 Female 8 Amanfrom, GH 2011 Neg Neg Neg Neg 
GH-S 10 Female 7 Amanfrom, GH 2011 Neg Neg Neg Neg 
GH-S 11 Female 7 Amanfrom, GH 2011 Neg Neg Neg Neg 
GH-S 12 Female 1.5 Sokoban New Town, GH 2011 Neg Neg Neg Neg 
GH-S 13 Male 6 Dompoase, GH 2011 Neg Neg Neg Neg 
GH-S 14 Male 8 Dompoase, GH 2011 Neg Neg Neg Neg 
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Sample ID Sex 
Age, 
mo† Origin 
 rIFA Viral RNA 
Year GOLV HEBV GOLV HEBV 
GH-S 15 Male 6 Dompoase, GH 2011 Neg Neg Neg Neg 
GH-S 16 Female 1.5 Sokoban New Town, GH 2011 Neg Neg Neg Neg 
GH-S 17 Female 6 Sokoban New Town, GH 2011 Neg Neg Neg Neg 
GH-S 18 Male 1.5 Sokoban New Town, GH 2011 Neg Neg Neg Neg 
GH-S 19 Male 6 Sokoban New Town, GH 2011 Neg Neg Neg Neg 
GH-S 20 Male 6 Sokoban New Town, GH 2011 Neg Neg Neg Neg 
GH-S 21 Female 8 Dompoase, GH 2011 Neg Neg Neg Neg 
GH-S 22 Male 6 Dompoase, GH 2011 Neg Neg Neg Neg 
GH-S 23 Male 6 Dompoase, GH 2011 Neg Neg Neg Neg 
GH-S 24 Male 6 Dompoase, GH 2011 Neg Neg Neg Neg 
GH-S 25 Female 6 Dompoase, GH 2011 Neg Neg Neg Neg 
GH-S 26 Male 8 Dompoase, GH 2011 Neg Neg Neg Neg 
GH-S 27 Female 6 Dompoase, GH 2011 Neg Neg Neg Neg 
GH-S 28 Female 8 Dompoase, GH 2011 Neg Neg Neg Neg 
GH-S 31 Male 5 Dompoase, GH 2011 Neg Neg Neg Neg 
GH-S 32 Male 5 Dompoase, GH 2011 Neg Neg Neg Neg 
GH-S 33 Female 5 Akropong, GH 2011 Neg Neg Neg Neg 
GH-S 34 Male 5 Akropong, GH 2011 Neg Neg Neg Neg 
GH-S 35 Male 5 Akropong, GH 2011 Neg Neg Neg Neg 
GH-S 36 Male 5 Akropong, GH 2011 Neg Neg Neg Neg 
GH-S 37 Female 5 Akropong, GH 2011 Neg Neg Neg Neg 
GH-S 38 Female 7 Akropong, GH 2011 Neg Neg Neg Neg 
GH-S 39 Female 7 Akropong, GH 2011 Neg Neg Neg Neg 
GH-S 40 Male 6 Akropong, GH 2011 Neg Neg Neg Neg 
GH-S 41 Male 6 Akropong 2, GH 2011 Neg Neg Neg Neg 
GH-S 42 Male 6 Akropong 2, GH 2011 Neg Neg Neg Neg 
GH-S 43 Male 6 Akropong, GH 2011 Neg Neg Neg Neg 
GH-S 44 Female 6 Akropong, GH 2011 Neg Neg Neg Neg 
GH-S 45 Female 6 Akropong, GH 2011 Neg Neg Neg Neg 
GH-S 46 Male 5 Akropong, GH 2011 Neg Neg Neg Neg 
GH-S 47 Female 5 Akropong, GH 2011 Neg Neg Neg Neg 
GH-S 48 Male 5 Akropong, GH 2011 Neg Neg Neg Neg 
GH-S 49 Female 5 Akropong, GH 2011 Neg Neg Neg Neg 
GH-S 50 Female 6 Akropong 2, GH 2011 Neg Neg Neg Neg 
GH-S 51 Female 6 Akropong 2, GH 2011 Neg Neg Neg Neg 
GH-S 52 Male 6 Akropong 2, GH 2011 Neg Neg Neg Neg 
GH-S 53 Male 7 Akropong 2, GH 2011 Neg Neg Neg Neg 
GH-S 54 Male 7 Akropong 2, GH 2011 Neg Neg Neg Neg 
GH-S 55 Female 7 Akropong 2, GH 2011 Neg Neg Neg Neg 
GH-S 56 Female 7 Akropong 2, GH 2011 Neg Neg Neg Neg 
GH-S 57 Male 7 Akropong 2, GH 2011 Neg Neg Neg Neg 
GH-S 58 Male 5 Essienimpong, GH 2011 Neg Neg Neg Neg 
GH-S 59 Female 6 Essienimpong, GH 2011 Neg Neg Neg Neg 
GH-S 60 Male 5 Essienimpong, GH 2011 Neg Neg Neg Neg 
GH-S 61 Male 5 Essienimpong, GH 2011 Neg Neg Neg Neg 
GH-S 62 Male 4 Akropong 2, GH 2011 Neg Neg Neg Neg 
GH-S 63 Female 4 Akropong 2, GH 2011 Neg Neg Neg Neg 
GH-S 64 Male 4 Akropong 2, GH 2011 Neg Neg Neg Neg 
GH-S 65 Female 4 Akropong 2, GH 2011 Neg Neg Neg Neg 
GH-S 66 Female 4 Akropong 2, GH 2011 Neg Neg Neg Neg 
GH-S 67 Male 5 Essienimpong, GH 2011 Neg Neg Neg Neg 
GH-S 68 Female 5 Essienimpong, GH 2011 Neg Neg Neg Neg 
GH-S 69 Female 5 Essienimpong, GH 2011 Neg Neg Neg Neg 
GH-S 70 Female 5 Essienimpong, GH 2011 Neg Neg Neg Neg 
GH-S 71 Female 6 Essienimpong, GH 2011 Neg Neg Neg Neg 
GH-S 72 Female 6 Essienimpong, GH 2011 Neg Neg Neg Neg 
GH-S 73 Female 8 Onwe, GH 2011 Neg Neg Neg Neg 
GH-S 74 Female 8 Onwe, GH 2011 Neg Neg Neg Neg 
GH-S 75 Female 8 Onwe, GH 2011 Neg Neg Neg Neg 
GH-S 76 Male 8 Onwe, GH 2011 Neg Neg Neg Neg 
GH-S 77 Male 8 Onwe, GH 2011 Neg Neg Neg Neg 
GH-S 78 Female 5 Onwe, GH 2011 Neg Neg Neg Neg 
GH-S 79 Male 8 Onwe, GH 2011 Neg Neg Neg Neg 
GH-S 80 Female 8 Onwe, GH 2011 Neg Neg Neg Neg 
GH-S 81 Female 5 Onwe, GH 2011 Neg Neg Neg Neg 
GH-S 82 Female 5 Onwe, GH 2011 Neg Neg Neg Neg 
GH-S 83 Female 7 Ejisu Krapa, GH 2011 Neg Neg Neg Neg 
GH-S 84 Female 7 Ejisu Krapa, GH 2011 Neg Neg Neg Neg 
GH-S 85 Female 7 Ejisu Krapa, GH 2011 Neg Neg Neg Neg 
GH-S 86 Female 7 Ejisu Krapa, GH 2011 Neg Neg Neg Neg 
GH-S 87 Male 7 Ejisu Krapa, GH 2011 Neg Neg Neg Neg 
GH-S 89 Female 5 Ejisu Krapa, GH 2011 Neg Neg Neg Neg 
GH-S 90 Female 5 Ejisu Krapa, GH 2011 Neg Neg Neg Neg 
 Page 5 of 8 
Sample ID Sex 
Age, 
mo† Origin 
 rIFA Viral RNA 
Year GOLV HEBV GOLV HEBV 
GH-S 91 Male 4 Ejisu Krapa, GH 2011 Neg Neg Neg Neg 
GH-S 92 Female 5 Ejisu Krapa, GH 2011 Neg Neg Neg Neg 
GH-S 93 Female 12 Abattoir, GH 2011 Neg Neg Neg Neg 
GH-S 94 Female 12 Abattoir, GH 2011 Neg Neg Neg Neg 
GH-S 95 Female 12 Abattoir, GH 2011 Neg Neg Neg Neg 
GH-S 96 Male 12 Abattoir, GH 2011 Neg Neg Neg Neg 
GH-S 97 Male 12 Abattoir, GH 2011 Neg Neg Neg Neg 
GH-S 98 Female 12 Abattoir, GH 2011 Neg Neg Neg Neg 
GH-S 99 Male 12 Abattoir, GH 2011 Neg Neg Neg Neg 
GH-S 100 Female 12 Abattoir, GH 2011 Neg Neg Neg Neg 
GH-S 101 Female 12 Abattoir, GH 2011 Neg Neg Neg Neg 
GH-S 102 Male 12 Abattoir, GH 2011 Neg Neg Neg Neg 
GH-S 103 Female 12 Abattoir, GH 2011 Neg Neg Neg Neg 
GH-S 104 Female 5 Abattoir, GH 2011 Neg Neg Neg Neg 
GH-S 105 Female 12 Abattoir, GH 2011 Neg Neg Neg Neg 
GH-S 106 Female 4 Abattoir, GH 2011 Neg Neg Neg Neg 
GH-S 107 Male 12 Abattoir, GH 2011 Neg Neg Neg Neg 
GH-S 108 Female 12 Abattoir, GH 2011 Neg Neg Neg Neg 
*CI, Côte dIvoire; GH, Ghana; GOLV, Gouléako virus; HEBV, Herbert virus; Neg, Negative results.  




Technical Appendix Figure 1. Immunofluorescence patterns for antibodies against Gouléako virus 
(GOLV) and Herbert virus (HEBV) in serum samples from swine, Côte dIvoire (CI), 2008, and Ghana, 
2011. Figure shows representative results from 1 pig (labeled CI-S 09) from which serum was tested 
against overexpressed recombinant nucleocapsid protein of A) GOLV and B) HEBV in VeroB4 cells. 
Anti-FLAG IgG antibodies were used to control for overexpression of C) GOLV-nucleocapsid (N) and 
D) HEBV-N. Scale bar indicates 20 μm. All photographs were taken at equivalent exposure settings. 
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Technical Appendix Figure 2. Alignment of Gouléako virus (GOLV) strains from mosquitoes 
originating from Côte d’Ivoire and Ghana and swine sampled in Korea. A) Alignment of the GOLV 
nucleocapsid proteins; B) alignment of complete GOLV glycoprotein precursor protein from mosquito 
and of protein fragments identified in swine. Schematic overview of encoded proteins is shown in 
boxes. Transmembrane domains are marked in yellow. Protein domains located outside virions are 
shown in dark blue, and those located inside virions are in light blue. C) Alignment of Gc proteins 
originating from mosquitoes and swine. A red line (at consensus identity 29 and 30) marks sequences 
from swine published by Chung et al. in 2014 (4). 
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Technical Appendix Figure 3. Alignment of Herbert virus (HEBV) strains from mosquitoes and pigs. 
A) Overview of location of amplified RNA-dependent RNA polymerase (RdRp) protein sequences 
available from mosquitoes and swine. Sequences detected in swine in South Korea are indicated by a 
red line. B) Alignment of RdRp sequences from mosquitoes and swine. Amino acid changes are 
colored. Sequences detected in swine in South Korea are indicated by a red line. C) Alignment of 
HEBV protein sequences of the third conserved region of the RdRp identified in mosquitoes from 
Côte d’Ivoire and Ghana.  
